Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Therasse

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 29, 2000
Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer studyD Curran, N Aaronson, B Standaert, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2005
Health related quality of life outcomes in cancer clinical trialsA Bottomley, H Flechtner, F Efficace, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2003
Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysisJ A van der Hage, H Putter, J Bonnema, et al.
Cancer Investigation|March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development NetworkD Lacombe, A Butler-Smith, P Therasse, et al.
Critical Reviews in Oncology/Hematology|September 10, 2003
Quality assurance in clinical trialsP B Ottevanger, P Therasse, C van de Velde, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2008
Recommendations for the assessment of progression in randomised cancer treatment trialsJ E Dancey, L E Dodd, R Ford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter studyP Therasse, L Mauriac, M Welnicka-Jaskiewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
Statistical methodology of phase III cancer clinical trials: advances and future perspectivesR Sylvester, M Van Glabbeke, L Collette, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2008
Lessons learned from independent central reviewR Ford, L Schwartz, J Dancey, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2003
Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trialsG Atalay, L Biganzoli, F Renard, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|April 29, 2000
Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer studyD Curran, N Aaronson, B Standaert, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2005
Health related quality of life outcomes in cancer clinical trialsA Bottomley, H Flechtner, F Efficace, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2003
Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysisJ A van der Hage, H Putter, J Bonnema, et al.
Cancer Investigation|March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development NetworkD Lacombe, A Butler-Smith, P Therasse, et al.
Critical Reviews in Oncology/Hematology|September 10, 2003
Quality assurance in clinical trialsP B Ottevanger, P Therasse, C van de Velde, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2008
Recommendations for the assessment of progression in randomised cancer treatment trialsJ E Dancey, L E Dodd, R Ford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter studyP Therasse, L Mauriac, M Welnicka-Jaskiewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
Statistical methodology of phase III cancer clinical trials: advances and future perspectivesR Sylvester, M Van Glabbeke, L Collette, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2008
Lessons learned from independent central reviewR Ford, L Schwartz, J Dancey, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2003
Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trialsG Atalay, L Biganzoli, F Renard, et al.
Pageof 6